No Result
View All Result
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
Smart Investment Today
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Smart Investment Today
No Result
View All Result
Home Editor's Pick

Pharms v. United States Brief: Judges Shouldn’t Sentence People for Things the Jury Found They Didn’t Do

by
April 17, 2026
in Editor's Pick
0
Pharms v. United States Brief: Judges Shouldn’t Sentence People for Things the Jury Found They Didn’t Do
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Matthew Cavedon

Keith Pharms was arrested and charged with five counts involving a gunfight between, among others, Mr. Pharms and a police officer. The jury was specifically asked whether Mr. Pharms fired a weapon. The jury said no.

Despite this finding, the district judge sentenced Mr. Pharms as if he had used a firearm, lengthening the sentence he could receive by at least four and a half years. This miscarriage of justice is part of a common practice called acquitted conduct sentencing.

Sentencing defendants based on conduct for which they were acquitted undermines the critical role that juries play in the American justice system in three ways. First, it undermines the historic discretion that our Anglo-American legal tradition gives to juries. Second, it prevents juries from serving their role as a check on potential government misconduct. Finally, it diminishes the legitimacy that involving the community in the criminal justice system provides.

The Cato Institute filed a brief urging the Supreme Court to take up this case and grant this petition for certiorari to end the practice of acquitted conduct sentencing.

Previous Post

Jesus and the Christian Socialist’s Problem of Evil

Next Post

Will Trump’s Next Tariffs Be a “Sham,” Too?

Next Post
Will Trump’s Next Tariffs Be a “Sham,” Too?

Will Trump’s Next Tariffs Be a “Sham,” Too?

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • Trending
    • Comments
    • Latest
    Pibit.AI raises $7m Series A to bring trusted AI underwriting to the insurance sector

    Pibit.AI raises $7m Series A to bring trusted AI underwriting to the insurance sector

    November 20, 2025

    Gold Prices Rise as the Dollar Slowly Dies

    May 25, 2024

    Richard Murphy, The Bank of England, And MMT Confusion

    March 15, 2025

    We Can’t Fix International Organizations like the WTO. Abolish Them.

    March 15, 2025
    The £4.8bn India deal is the starting gun, not the prize

    The £4.8bn India deal is the starting gun, not the prize

    0

    Ana-Maria Coaching Marks Milestone with New Book Release

    0

    New Bonded Warehouse Facilities Launched in Immingham

    0

    From Corporate Burnout to High-Performance Coach: Anna Mosley’s Inspiring Journey with ‘Eighty’

    0
    The £4.8bn India deal is the starting gun, not the prize

    The £4.8bn India deal is the starting gun, not the prize

    July 16, 2026

    Grünenthal Enhances Genetic Medicine Expertise by Joining the Munich Cluster for Nucleic Acid Therapeutics

    July 16, 2026
    SpaceX slips below IPO price as UK investors’ £271m bet turns sour

    SpaceX slips below IPO price as UK investors’ £271m bet turns sour

    July 16, 2026
    Burnham told to move fast on devolution or risk a two-tier England

    Burnham told to move fast on devolution or risk a two-tier England

    July 16, 2026

    Recent News

    The £4.8bn India deal is the starting gun, not the prize

    The £4.8bn India deal is the starting gun, not the prize

    July 16, 2026

    Grünenthal Enhances Genetic Medicine Expertise by Joining the Munich Cluster for Nucleic Acid Therapeutics

    July 16, 2026
    SpaceX slips below IPO price as UK investors’ £271m bet turns sour

    SpaceX slips below IPO price as UK investors’ £271m bet turns sour

    July 16, 2026
    Burnham told to move fast on devolution or risk a two-tier England

    Burnham told to move fast on devolution or risk a two-tier England

    July 16, 2026
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 smartinvestmenttoday.com | All Rights Reserved

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2026 smartinvestmenttoday.com | All Rights Reserved